BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15502007)

  • 1. Metabolism, pharmacokinetics, and protein covalent binding of radiolabeled MaxiPost (BMS-204352) in humans.
    Zhang D; Krishna R; Wang L; Zeng J; Mitroka J; Dai R; Narasimhan N; Reeves RA; Srinivas NR; Klunk LJ
    Drug Metab Dispos; 2005 Jan; 33(1):83-93. PubMed ID: 15502007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein covalent binding of maxipost through a cytochrome P450-mediated ortho-quinone methide intermediate in rats.
    Zhang D; Ogan M; Gedamke R; Roongta V; Dai R; Zhu M; Rinehart JK; Klunk L; Mitroka J
    Drug Metab Dispos; 2003 Jul; 31(7):837-45. PubMed ID: 12814959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide N-glucuronidation of MaxiPost catalyzed by UDP-glucuronosyltransferase 2B7 in humans.
    Zhang D; Zhao W; Roongta VA; Mitroka JG; Klunk LJ; Zhu M
    Drug Metab Dispos; 2004 May; 32(5):545-51. PubMed ID: 15100177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
    Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disposition of [14C]bazedoxifene in healthy postmenopausal women.
    Chandrasekaran A; McKeand WE; Sullivan P; DeMaio W; Stoltz R; Scatina J
    Drug Metab Dispos; 2009 Jun; 37(6):1219-25. PubMed ID: 19273530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dose and input rate on the brain penetration of BMS-204352 following intravenous administration to rats.
    Krishna R; Palme H; Zeng J; Srinivas N
    Biopharm Drug Dispos; 2002 Sep; 23(6):227-31. PubMed ID: 12214322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats.
    Krishna R; Shah VR; Srinivas N
    Biopharm Drug Dispos; 2002 Sep; 23(6):233-7. PubMed ID: 12214323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of radiolabeled BMS-204352 in rats and dogs.
    Krishna R; Yao M; Srinivas NR; Shah V; Pursley JM; Arnold M; Vachharajani NN
    Biopharm Drug Dispos; 2002 Jan; 23(1):41-6. PubMed ID: 11891672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, metabolism, and excretion of [(14)C]MK-0524, a prostaglandin D(2) receptor antagonist, in humans.
    Karanam B; Madeira M; Bradley S; Wenning L; Desai R; Soli E; Schenk D; Jones A; Dean B; Doss G; Garrett G; Crumley T; Nirula A; Lai E
    Drug Metab Dispos; 2007 Jul; 35(7):1196-202. PubMed ID: 17431030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative metabolism of 14C-labeled apixaban in mice, rats, rabbits, dogs, and humans.
    Zhang D; He K; Raghavan N; Wang L; Mitroka J; Maxwell BD; Knabb RM; Frost C; Schuster A; Hao F; Gu Z; Humphreys WG; Grossman SJ
    Drug Metab Dispos; 2009 Aug; 37(8):1738-48. PubMed ID: 19420130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition of [14C]ruboxistaurin in humans.
    Burkey JL; Campanale KM; Barbuch R; O'Bannon D; Rash J; Benson C; Small D
    Drug Metab Dispos; 2006 Nov; 34(11):1909-17. PubMed ID: 16896067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism, excretion, and pharmacokinetics of [14C]tigecycline, a first-in-class glycylcycline antibiotic, after intravenous infusion to healthy male subjects.
    Hoffmann M; DeMaio W; Jordan RA; Talaat R; Harper D; Speth J; Scatina J
    Drug Metab Dispos; 2007 Sep; 35(9):1543-53. PubMed ID: 17537869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism distribution and excretion of a matrix metalloproteinase-13 inhibitor, 4-[4-(4-fluorophenoxy)-benzenesulfonylamino]tetrahydropyran-4-carboxylic acid hydroxyamide (CP-544439), in rats and dogs: assessment of the metabolic profile of CP-544439 in plasma and urine of humans.
    Dalvie D; Cosker T; Boyden T; Zhou S; Schroeder C; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1869-83. PubMed ID: 18566038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
    Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH
    Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, metabolism, and excretion of torcetrapib, a cholesteryl ester transfer protein inhibitor, in humans.
    Dalvie D; Chen W; Zhang C; Vaz AD; Smolarek TA; Cox LM; Lin J; Obach RS
    Drug Metab Dispos; 2008 Nov; 36(11):2185-98. PubMed ID: 18694908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
    Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
    Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.